In rodent models of systemic inflammation, atherosclerosis, and non-alcoholic steatohepatitis (NASH), PPARα exerts negative regulation on pro-inflammatory and acute phase response signaling pathways [60,61]. Here, PPARA is linked to atherosclerosis.